EPE Special Opportunities' net asset value per share rose to 187.89p in the six months to the end of July - up 17.4%.
The share price at 31 July was 148.50 pence, representing an increase of 19.3% on the share price of 124.50 pence as at 31 January.
On 4 July, the company announced the completion of a merger of Pharmacy2U and ChemD Holdings, which trades as ChemistDirect.co.uk. In conjunction with the merger, the Business Growth Fund has invested £10.0 million to support ambitious growth plans.
ESO says the portfolio remains conservatively valued with a weighted average enterprise value equating to an EBITDA multiple of 6.1x for mature assets and equating to a sales multiple of 0.5x for assets investing for sales growth.
(LON:ESO) EPE Special Opportunities Plc share price was 0p at 152.5p